Molzym announces new Board of Directors to accelerate growth of its molecular diagnostic solutions
Molzym GmbH & Co. KG, a unique manufacturer of broad-range molecular diagnostic solutions is pleased to announce the appointment of new Board members to support and accelerate the company´s global growth.
Since Gradian acquired Molzym in December 2019, the highly experienced and scientific team has been entirely focused on growth, bringing new skills on-board, reviewing its sales strategy and business model, and accelerating its R&D pipeline to meet current and future market challenges and needs.